<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37488524</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1528-3658</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Molecular medicine (Cambridge, Mass.)</Title><ISOAbbreviation>Mol Med</ISOAbbreviation></Journal><ArticleTitle>Knockdown of DEC2 expression inhibits the proliferation of mesangial cells through suppressed glycolysis and p38 MAPK/Erk pathway in lupus nephritis.</ArticleTitle><Pagination><StartPage>99</StartPage><MedlinePgn>99</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">99</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s10020-023-00672-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">To elucidate the mechanism by which DEC2 modulates the proliferation of mesangial cells (MCs) in lupus nephritis (LN).</AbstractText><AbstractText Label="METHODS">The 32-week-old female Fcgr2b<sup>-/-</sup> mice and their serum-treated MCs were used as in vivo and in vitro LN model. MCs knocked down of DEC2 and overexpressed with DEC2 were also established. The expression of DEC2 was measured in the kidneys of Fcgr2b<sup>-/-</sup> mice and LN serum-treated MCs using RT-qPCR and Western blot. MCs proliferation was detected by 5-ethynyl-2'-deoxyuridine (EdU) labeling assay and PCNA expression using immunofluorescence. The glucose metabolism was evaluated in LN serum-treated MCs, and the levels of lactate production, glucose consumption, ATP production and mitochondrial membrane potential were assayed. The glycolysis and mitochondrial respiration function of the MCs were measured using the Extracellular Flux Analyzer. The extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were dynamically monitored and multiple important bioenergetic parameters can be calculated. The expression of Toll like receptor 4 (TLR4) and glucose transporter 1 (GLUT1) were detected in the MCs. Multiple signaling proteins were screened.</AbstractText><AbstractText Label="RESULTS">DEC2 was found overexpressed in the kidney of Fcgr2b<sup>-/-</sup> LN mice. Knockdown of DEC2 inhibited LN serum-induced MCs proliferation. DEC2 was associated with the glucose metabolism in LN serum-treated MCs. DEC2 regulated glycolysis in LN serum-treated MCs. DEC2 was associated with mitochondrial fitness in LN serum treated MCs. DEC2 activated MCs glycolysis through TLR4 and glucose transporter 1 (GLUT1) regulation. DEC2 regulated MCs proliferation through two signaling pathways including dependent and independent of glycolysis, which located in the downstream of TLR4 signaling.</AbstractText><AbstractText Label="CONCLUSION">Knockdown of DEC2 expression inhibits the proliferation of MCs through suppressed glycolysis and p38 MAPK/ERK pathway in LN.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Huimeng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Practice, Fuyang Hospital of Anhui Medical University, Fuyang, 236000, Anhui Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-3351-4038</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong Province, China. liuqiang@ahmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Med</MedlineTA><NlmUniqueID>9501023</NlmUniqueID><ISSNLinking>1076-1551</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051272">Glucose Transporter Type 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Mol Med. 2023 Sep 14;29(1):124</RefSource><PMID Version="1">37710155</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050527" MajorTopicYN="N">Mesangial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051272" MajorTopicYN="N">Glucose Transporter Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006019" MajorTopicYN="N">Glycolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bioenergetics</Keyword><Keyword MajorTopicYN="N">DEC2</Keyword><Keyword MajorTopicYN="N">Glycolysis</Keyword><Keyword MajorTopicYN="N">Lupus nephritis</Keyword><Keyword MajorTopicYN="N">Mesangial cells</Keyword></KeywordList><CoiStatement>The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as potential competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>25</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>23</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37488524</ArticleId><ArticleId IdType="pmc">PMC10364423</ArticleId><ArticleId IdType="doi">10.1186/s10020-023-00672-z</ArticleId><ArticleId IdType="pii">10.1186/s10020-023-00672-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499&#x2013;511. doi: 10.1038/nri1391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1391</ArticleId><ArticleId IdType="pubmed">15229469</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12:825&#x2013;835. doi: 10.2215/CJN.05780616.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05780616</ArticleId><ArticleId IdType="pmc">PMC5477208</ArticleId><ArticleId IdType="pubmed">27821390</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchereau R, et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell. 2016;165:1548&#x2013;1550. doi: 10.1016/j.cell.2016.05.057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.05.057</ArticleId><ArticleId IdType="pubmed">27259156</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck GM, et al. ADAM17 promotes proliferation of collecting duct kidney epithelial cells through ERK activation and increased glycolysis in polycystic kidney disease. Am J Physiol Renal Physiol. 2015;307:F551. doi: 10.1152/ajprenal.00218.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00218.2014</ArticleId><ArticleId IdType="pmc">PMC4154111</ArticleId><ArticleId IdType="pubmed">24899059</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke J. Voclosporin improves outcomes in lupus nephritis. Nat Rev Rheumatol. 2021;17:378. doi: 10.1038/s41584-021-00638-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00638-7</ArticleId><ArticleId IdType="pubmed">34040229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebefors K, Nystr&#xf6;m J. New insights into crosstalk in the kidney. Curr Opin Nephrol Hypertens. 2017;26:143&#x2013;147. doi: 10.1097/MNH.0000000000000310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MNH.0000000000000310</ArticleId><ArticleId IdType="pubmed">28198735</ArticleId></ArticleIdList></Reference><Reference><Citation>Everts B, et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation. Nat Immunol. 2014;15:323&#x2013;332. doi: 10.1038/ni.2833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2833</ArticleId><ArticleId IdType="pmc">PMC4358322</ArticleId><ArticleId IdType="pubmed">24562310</ArticleId></ArticleIdList></Reference><Reference><Citation>Honma S, et al. Dec1 and Dec2 are regulators of the mammalian molecular clock. Nature. 2002;419:841&#x2013;844. doi: 10.1038/nature01123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01123</ArticleId><ArticleId IdType="pubmed">12397359</ArticleId></ArticleIdList></Reference><Reference><Citation>Imaizumi T, et al. Basic-helix-loop-helix transcription factor DEC2 constitutes negative feedback loop in IFN-&#x3b2;-mediated inflammatory responses in human mesangial cells. Immunol Lett. 2011;136:37&#x2013;43. doi: 10.1016/j.imlet.2010.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imlet.2010.11.009</ArticleId><ArticleId IdType="pubmed">21129405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato Y, Kawamoto T, Fujimoto K, Noshiro M. DEC1/STRA13/SHARP2 and DEC2/SHARP1 coordinate physiological processes, including circadian rhythms in response to environmental stimuli. Curr Top Dev Biol. 2014;110:339&#x2013;372. doi: 10.1016/B978-0-12-405943-6.00010-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-405943-6.00010-5</ArticleId><ArticleId IdType="pubmed">25248482</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczyk CM, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115:4742&#x2013;4749. doi: 10.1182/blood-2009-10-249540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-10-249540</ArticleId><ArticleId IdType="pmc">PMC2890190</ArticleId><ArticleId IdType="pubmed">20351312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok SK, Tsokos GC. New insights into the role of renal resident cells in the pathogenesis of lupus nephritis. Korean J Intern Med. 2018;33:284&#x2013;289. doi: 10.3904/kjim.2017.383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2017.383</ArticleId><ArticleId IdType="pmc">PMC5840601</ArticleId><ArticleId IdType="pubmed">29320847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lech M, Anders HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol. 2013;24:1357&#x2013;1366. doi: 10.1681/ASN.2013010026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013010026</ArticleId><ArticleId IdType="pmc">PMC3752952</ArticleId><ArticleId IdType="pubmed">23929771</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, et al. Knockdown of TRIM27 expression suppresses the dysfunction of mesangial cells in lupus nephritis by FoxO1 pathway. J Cell Physiol. 2019;234:11555&#x2013;11566. doi: 10.1002/jcp.27810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27810</ArticleId><ArticleId IdType="pubmed">30648253</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441&#x2013;464. doi: 10.1146/annurev-cellbio-092910-154237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-092910-154237</ArticleId><ArticleId IdType="pubmed">21985671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21:669&#x2013;680. doi: 10.1038/s41568-021-00378-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-021-00378-6</ArticleId><ArticleId IdType="pubmed">34272515</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowling TK. Mesangial cells in lupus nephritis. Curr Rheumatol Rep. 2022;23:83. doi: 10.1007/s11926-021-01048-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-021-01048-0</ArticleId><ArticleId IdType="pubmed">34985599</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisitkun P, et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity. 2012;37:1104&#x2013;1115. doi: 10.1016/j.immuni.2012.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.08.014</ArticleId><ArticleId IdType="pmc">PMC3594848</ArticleId><ArticleId IdType="pubmed">23123062</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi H, Cao Q, Liu Q. MicroRNA-16 directly binds to DEC2 and inactivates the TLR4 signaling pathway to inhibit lupus nephritis-induced kidney tissue hyperplasia and mesangial cell proliferation. Int Immunopharmacol. 2020;88:106859. doi: 10.1016/j.intimp.2020.106859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106859</ArticleId><ArticleId IdType="pubmed">32795896</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannahill GM, O'Neill LA. The emerging role of metabolic regulation in the functioning of Toll-like receptors and the NOD-like receptor Nlrp3. FEBS Lett. 2011;585:1568&#x2013;1572. doi: 10.1016/j.febslet.2011.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2011.05.008</ArticleId><ArticleId IdType="pubmed">21565193</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung CW, Hsu YC, Shih YH, Chang PJ, Lin CL. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy. Nephrology (Carlton) 2018;23(Suppl 4):32&#x2013;37. doi: 10.1111/nep.13451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.13451</ArticleId><ArticleId IdType="pubmed">30298646</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung S, Chan TM. Anti-dsDNA antibodies and resident renal cells&#x2014;their putative roles in pathogenesis of renal lesions in lupus nephritis. Clin Immunol. 2017;185:40&#x2013;50. doi: 10.1016/j.clim.2016.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.09.002</ArticleId><ArticleId IdType="pubmed">27612436</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Li Q, Ouyang Q, Wu L, Chen X. Activated mesangial cells acquire the function of antigen presentation. Cell Immunol. 2021;361:104279. doi: 10.1016/j.cellimm.2020.104279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2020.104279</ArticleId><ArticleId IdType="pubmed">33422698</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019;20:436&#x2013;450. doi: 10.1038/s41580-019-0123-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0123-5</ArticleId><ArticleId IdType="pmc">PMC6592760</ArticleId><ArticleId IdType="pubmed">30976106</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>